ロード中...
Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer
Neoadjuvant chemotherapy (NAC) has drawn more attention to the treatment of locally advanced gastric cancer (AGC) in the current multidisciplinary treatment model. EORTC trial 40954 has recently reported that NAC plus surgery without postoperative adjuvant chemotherapy could not benefit the locally...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Co., Limited
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3218147/ https://ncbi.nlm.nih.gov/pubmed/22110287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i40.4542 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|